LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 260

Search options

  1. Article ; Online: New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement.

    Mladenov, Emil / Mladenova, Veronika / Stuschke, Martin / Iliakis, George

    International journal of molecular sciences

    2023  Volume 24, Issue 19

    Abstract: Radiation therapy is an essential component of present-day cancer management, utilizing ionizing radiation (IR) of different modalities to mitigate cancer progression. IR functions by generating ionizations in cells that induce a plethora of DNA lesions. ...

    Abstract Radiation therapy is an essential component of present-day cancer management, utilizing ionizing radiation (IR) of different modalities to mitigate cancer progression. IR functions by generating ionizations in cells that induce a plethora of DNA lesions. The most detrimental among them are the DNA double strand breaks (DSBs). In the course of evolution, cells of higher eukaryotes have evolved four major DSB repair pathways: classical non-homologous end joining (c-NHEJ), homologous recombination (HR), alternative end-joining (alt-EJ), and single strand annealing (SSA). These mechanistically distinct repair pathways have different cell cycle- and homology-dependencies but, surprisingly, they operate with widely different fidelity and kinetics and therefore contribute unequally to cell survival and genome maintenance. It is therefore reasonable to anticipate tight regulation and coordination in the engagement of these DSB repair pathway to achieve the maximum possible genomic stability. Here, we provide a state-of-the-art review of the accumulated knowledge on the molecular mechanisms underpinning these repair pathways, with emphasis on c-NHEJ and HR. We discuss factors and processes that have recently come to the fore. We outline mechanisms steering DSB repair pathway choice throughout the cell cycle, and highlight the critical role of DNA end resection in this process. Most importantly, however, we point out the strong preference for HR at low DSB loads, and thus low IR doses, for cells irradiated in the G
    MeSH term(s) Humans ; DNA Breaks, Double-Stranded ; DNA Repair ; DNA End-Joining Repair ; DNA ; Homologous Recombination ; Genomic Instability ; Radiation Dosage
    Chemical Substances DNA (9007-49-2)
    Language English
    Publishing date 2023-10-06
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms241914956
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Combined radiation- and immune checkpoint-inhibitor-induced pneumonitis - The challenge to predict and detect overlapping immune-related adverse effects from evolving laboratory biomarkers and clinical imaging.

    Guberina, Nika / Wirsdörfer, Florian / Stuschke, Martin / Jendrossek, Verena

    Neoplasia (New York, N.Y.)

    2023  Volume 39, Page(s) 100892

    Abstract: The risk of overlapping pulmonary toxicity induced by thoracic radio(chemo)therapy and immune checkpoint inhibitor therapy in the treatment of patients suffering from non-small cell lung cancer (NSCLC) is one important challenge in successful ... ...

    Abstract The risk of overlapping pulmonary toxicity induced by thoracic radio(chemo)therapy and immune checkpoint inhibitor therapy in the treatment of patients suffering from non-small cell lung cancer (NSCLC) is one important challenge in successful radioimmunotherapy. In the present opinion we highlight factors that we find important to be considered before treatment initiation, during the treatment sequence, and after treatment completion combined or sequential application of radio(chemo)therapy and immune checkpoint inhibitor therapy. A major aim is to optimize the therapeutic index and to avoid immune related adverse effects. The goals in the future will be focused not only on identifying patients already in the pretreatment phase who could benefit from this complex treatment, but also in identifying patients, who are most likely to have higher grade toxicity. In this respect, proper assessment of clinical performance status, monitoring for the presence of certain comorbidities, evaluation of laboratory parameters such as TGF-α and IL-6 levels, human leukocyte antigens (HLA), and consideration of other potential biomarkers which will evolve in near future are essential. Likewise, the critical parameters must be monitored during the treatment phase and follow-up care to detect potential side effects in time. With the help of high-end imaging which is already used on a daily basis in image guided radiotherapy (IGRT) for intensity modulated radiotherapy (IMRT), its advanced form volumetric modulated arc therapy (VMAT), and adaptive radiation therapy (ART), clinically relevant changes in lung tissue can be detected at an early stage of disease. Concurrent radiotherapy and immunotherapy requires a special focus on adverse events, particularly of the lung, but, when properly approached and applied, it may offer new perspectives for patients with locally advanced NSCLC to be seriously considered as a curative option.
    MeSH term(s) Humans ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/radiotherapy ; Lung Neoplasms/drug therapy ; Immune Checkpoint Inhibitors/adverse effects ; Radiotherapy, Intensity-Modulated/adverse effects ; Radiotherapy, Intensity-Modulated/methods ; Pneumonia/drug therapy ; Pneumonia/etiology
    Chemical Substances Immune Checkpoint Inhibitors
    Language English
    Publishing date 2023-04-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1483840-0
    ISSN 1476-5586 ; 1522-8002
    ISSN (online) 1476-5586
    ISSN 1522-8002
    DOI 10.1016/j.neo.2023.100892
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Lokale Strahlentherapie der Prostata mit Samenblasenbasis allein oder mit elektiver Bestrahlung pelviner Lymphknotenstationen beim Hochrisiko-Prostatakarzinom? : Ergebnisse der randomisierten POP-RT-Studie.

    Stuschke, Martin / Hadaschik, Boris

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al

    2021  Volume 197, Issue 10, Page(s) 939–942

    Title translation Radiation therapy in high-risk and very high-risk localized or locally advanced prostate cancer : Prostate-only versus prostate plus whole-pelvic?
    MeSH term(s) Androgen Antagonists ; Humans ; Male ; Pelvis ; Prostate ; Prostatic Neoplasms/radiotherapy
    Chemical Substances Androgen Antagonists
    Language German
    Publishing date 2021-09-02
    Publishing country Germany
    Document type Journal Article ; Comment
    ZDB-ID 84983-2
    ISSN 1439-099X ; 0179-7158 ; 0039-2073
    ISSN (online) 1439-099X
    ISSN 0179-7158 ; 0039-2073
    DOI 10.1007/s00066-021-01825-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Online: Ösophaguskarzinom

    Stahl, Michael / Batran, Salah-Eddin al- / Borner, Markus M. / Gockel, Ines / Grenacher, Lars / Hass, Holger G. / Köberle, Dieter / Möhler, Markus / Porschen, Rainer / Pritzkuleit, Ron / Rumpold, Holger / Stuschke, Martin / Sinn, Marianne

    Leitlinie - Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

    (Onkopedia Leitlinien)

    2022  

    Abstract: Ösophaguskarzinome machen in Deutschland ca. 1% aller malignen Erkrankungen und ca. 2% aller krebsbedingten Todesfälle aus. Klinisch relevant ist die Unterscheidung zwischen Plattenepithel- und Adenokarzinomen. Ca. 30-40% der Patient*innen befinden sich ... ...

    Institution Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
    Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie
    Schweizerische Gesellschaft für Medizinische Onkologie
    Schweizerische Gesellschaft für Hämatologie
    Deutsche Krebsgesellschaft / Arbeitsgemeinschaft für Internistische Onkologie
    Author's details DGHO - Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V., OeGHO - Österreichische Gesellschaft für Hämatologie & Medizinische Onkologie, SSMO/SSOM/SGMO - Schweizerische Gesellschaft für Medizinische Onkologie, SGH-SSH - Schweizerische Gesellschaft für Hämatologie/Société Suisse d'Hématologie, AIO - Arbeitsgemeinschaft für Internistische Onkologie ; Autoren: Michael Stahl, Salah-Eddin Al-Batran, Markus Borner, Ines Gockel, Lars Grenacher, Holger Hass, Dieter Köberle, Markus Möhler, Rainer Porschen, Ron Pritzkuleit, Holger Rumpold, Martin Stuschke, Marianne Sinn ; In Kooperation mit der AIO
    Series title Onkopedia Leitlinien
    Abstract Ösophaguskarzinome machen in Deutschland ca. 1% aller malignen Erkrankungen und ca. 2% aller krebsbedingten Todesfälle aus. Klinisch relevant ist die Unterscheidung zwischen Plattenepithel- und Adenokarzinomen. Ca. 30-40% der Patient*innen befinden sich bei Erstdiagnose prinzipiell in einem resektablen Stadium. Insbesondere bei Patient*innen mit einem Plattenepithelkarzinom sind häufig Komorbiditäten zu beachten mit einer daraus resultierenden eingeschränkten funktionellen Operabilität. Das 5-Jahres-Überleben mit alleiniger Resektion liegt um 20%. Multimodale Konzepte verbessern bei lokal fortgeschrittenen Tumoren die Prognose, sie können zudem einen Organerhalt ermöglichen. Nach präoperativer Chemoradiotherapie und kompletter Resektion besteht bei Patient*innen mit histologischem Tumorrest (nicht-PCR) eines Plattenepithelkarzinoms oder Adenokarzinoms (einschl. AEG 1) eine Indikation zum Einsatz einer adjuvanten Immuntherapie (unabhängig vom PD-L1 Status). Für metastasierte Plattenepithelkarzinome bleibt eine platinbasierte Chemotherapie trotz geringer Evidenz die Behandlung der Wahl. Der Einsatz von Checkpoint-Inhibitoren ist in Kombination mit Chemotherapie in der Erstlinie (PD-L1 CPS ≥ 10) und als Monotherapie (unabhängig vom PD-L1 Status) in der Zweitlinie zugelassen. Für die metastasierten Adenokarzinome des Ösophagus und des ösophago-gastralen Übergangs stehen in Analogie zum Magenkarzinom neben der kombinierten Chemotherapie auch personalisierte Therapieansätze (HER-2 positive Karzinome) und die Immuntherapie in Kombination mit Chemotherapie (PD-L1 CPS ≥ 5) zur Verfügung.
    Subject code 610
    Language German
    Size 1 Online-Ressource (50 Seiten), Diagramme
    Edition Stand: April 2022
    Publisher DGHO - Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V
    Publishing place Berlin
    Publishing country Germany
    Document type Book ; Online
    Note Open Access
    HBZ-ID HT021567315
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  5. Article ; Online: The p38/MK2 Pathway Functions as Chk1-Backup Downstream of ATM/ATR in G

    Luo, Daxian / Mladenov, Emil / Soni, Aashish / Stuschke, Martin / Iliakis, George

    Cells

    2023  Volume 12, Issue 10

    Abstract: We have recently reported that in ... ...

    Abstract We have recently reported that in G
    MeSH term(s) Phosphorylation ; Ataxia Telangiectasia Mutated Proteins/metabolism ; Cell Cycle Proteins/metabolism ; Radiation, Ionizing ; DNA/metabolism
    Chemical Substances Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1) ; Cell Cycle Proteins ; DNA (9007-49-2)
    Language English
    Publishing date 2023-05-14
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells12101387
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: DNA Damage Clustering after Ionizing Radiation and Consequences in the Processing of Chromatin Breaks.

    Mladenova, Veronika / Mladenov, Emil / Stuschke, Martin / Iliakis, George

    Molecules (Basel, Switzerland)

    2022  Volume 27, Issue 5

    Abstract: Charged-particle radiotherapy (CPRT) utilizing low and high linear energy transfer (low-/high-LET) ionizing radiation (IR) is a promising cancer treatment modality having unique physical energy deposition properties. CPRT enables focused delivery of a ... ...

    Abstract Charged-particle radiotherapy (CPRT) utilizing low and high linear energy transfer (low-/high-LET) ionizing radiation (IR) is a promising cancer treatment modality having unique physical energy deposition properties. CPRT enables focused delivery of a desired dose to the tumor, thus achieving a better tumor control and reduced normal tissue toxicity. It increases the overall radiation tolerance and the chances of survival for the patient. Further improvements in CPRT are expected from a better understanding of the mechanisms governing the biological effects of IR and their dependence on LET. There is increasing evidence that high-LET IR induces more complex and even clustered DNA double-strand breaks (DSBs) that are extremely consequential to cellular homeostasis, and which represent a considerable threat to genomic integrity. However, from the perspective of cancer management, the same DSB characteristics underpin the expected therapeutic benefit and are central to the rationale guiding current efforts for increased implementation of heavy ions (HI) in radiotherapy. Here, we review the specific cellular DNA damage responses (DDR) elicited by high-LET IR and compare them to those of low-LET IR. We emphasize differences in the forms of DSBs induced and their impact on DDR. Moreover, we analyze how the distinct initial forms of DSBs modulate the interplay between DSB repair pathways through the activation of DNA end resection. We postulate that at complex DSBs and DSB clusters, increased DNA end resection orchestrates an increased engagement of resection-dependent repair pathways. Furthermore, we summarize evidence that after exposure to high-LET IR, error-prone processes outcompete high fidelity homologous recombination (HR) through mechanisms that remain to be elucidated. Finally, we review the high-LET dependence of specific DDR-related post-translational modifications and the induction of apoptosis in cancer cells. We believe that in-depth characterization of the biological effects that are specific to high-LET IR will help to establish predictive and prognostic signatures for use in future individualized therapeutic strategies, and will enhance the prospects for the development of effective countermeasures for improved radiation protection during space travel.
    MeSH term(s) Chromatin/genetics ; Cluster Analysis ; DNA Breaks, Double-Stranded ; DNA Damage ; DNA Repair ; Humans ; Radiation, Ionizing
    Chemical Substances Chromatin
    Language English
    Publishing date 2022-02-24
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules27051540
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: ATR Contributes More Than ATM in Intra-S-Phase Checkpoint Activation after IR, and DNA-PKcs Facilitates Recovery: Evidence for Modular Integration of ATM/ATR/DNA-PKcs Functions.

    Soni, Aashish / Duan, Xiaolu / Stuschke, Martin / Iliakis, George

    International journal of molecular sciences

    2022  Volume 23, Issue 14

    Abstract: The intra-S-phase checkpoint was among the first reported cell cycle checkpoints in mammalian cells. It transiently slows down the rate of DNA replication after DNA damage to facilitate repair and thus prevents genomic instability. The ionizing radiation ...

    Abstract The intra-S-phase checkpoint was among the first reported cell cycle checkpoints in mammalian cells. It transiently slows down the rate of DNA replication after DNA damage to facilitate repair and thus prevents genomic instability. The ionizing radiation (IR)-induced intra-S-phase checkpoint in mammalian cells is thought to be mainly dependent upon the kinase activity of ATM. Defects in the intra-S-phase checkpoint result in radio-resistant DNA synthesis (RDS), which promotes genomic instability. ATM belongs to the PI3K kinase family along with ATR and DNA-PKcs. ATR has been shown to be the key kinase for intra-S-phase checkpoint signaling in yeast and has also been implicated in this checkpoint in higher eukaryotes. Recently, contributions of DNA-PKcs to IR-induced G
    MeSH term(s) Animals ; Ataxia Telangiectasia Mutated Proteins/genetics ; Ataxia Telangiectasia Mutated Proteins/metabolism ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; Checkpoint Kinase 1/metabolism ; DNA/metabolism ; DNA Damage ; DNA-Activated Protein Kinase/genetics ; Genomic Instability ; Humans ; Mammals/metabolism ; Phosphorylation ; Radiation, Ionizing
    Chemical Substances Cell Cycle Proteins ; DNA (9007-49-2) ; ATM protein, human (EC 2.7.11.1) ; ATR protein, human (EC 2.7.11.1) ; Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1) ; Checkpoint Kinase 1 (EC 2.7.11.1) ; DNA-Activated Protein Kinase (EC 2.7.11.1)
    Language English
    Publishing date 2022-07-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms23147506
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: 18

    Stuschke, Martin / Pöttgen, Christoph

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    2020  Volume 61, Issue Suppl 2, Page(s) 178S–179S

    MeSH term(s) Fluorodeoxyglucose F18 ; Humans ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/radiotherapy ; Positron Emission Tomography Computed Tomography ; Radiotherapy, Image-Guided
    Chemical Substances Fluorodeoxyglucose F18 (0Z5B2CJX4D)
    Language English
    Publishing date 2020-11-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80272-4
    ISSN 1535-5667 ; 0097-9058 ; 0161-5505 ; 0022-3123
    ISSN (online) 1535-5667
    ISSN 0097-9058 ; 0161-5505 ; 0022-3123
    DOI 10.2967/jnumed.120.251660
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Book ; Online ; Thesis: Synthetic lethality concepts for colon cancer cell lines in the background of mutations in the SWI/SNF complex

    Xu, Shan [Verfasser] / Stuschke, Martin [Akademischer Betreuer]

    2023  

    Author's details Shan Xu ; Betreuer: Martin Stuschke
    Keywords Biowissenschaften, Biologie ; Life Science, Biology
    Subject code sg570
    Language English
    Publisher Duisburg ; Universität Duisburg-Essen
    Publishing place Essen
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

  10. Book ; Online ; Thesis: ARID1B: eine neue Schwachstelle für die Radiosensitivität von ARID1A-mutierten kolorektalen Tumoren

    Niedermaier, Benedikt Walter [Verfasser] / Stuschke, Martin [Akademischer Betreuer]

    2023  

    Author's details Benedikt Walter Niedermaier ; Betreuer: Martin Stuschke
    Keywords Medizin, Gesundheit ; Medicine, Health
    Subject code sg610
    Language German
    Publisher Duisburg ; Universität Duisburg-Essen
    Publishing place Essen
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

To top